Effects of Acute Injection of Methylprednisolone in Man on Immunological and Non-Immunological Histamine Release from Leucocytes and Its Potentiation by Interleukin-3
[en] We investigated the effects of intravenous injection of methylprednisolone (MPR) compared with placebo (saline) on ex vivo leucocytic histamine release in eight healthy volunteers. All subjects received in a randomized and a single-blind manner the placebo and MPR, 20 mg and 125 mg, each injection given in 2 week intervals. On each occasion blood samples were taken just before and 24 h after the intravenous injection to determine circulating leucocyte counts and leucocytic histamine release induced by anti-IgE (1/2000) and FMP (Formyl-Methionyl-Phenylalanine) (10(-5) M) and its modulation by IL-3 (2 ng/ml). MPR 20 mg and 125 mg significantly increased circulating leucocyte counts (P < 0.05 and P < 0.001 respectively) but decreased leucocytic histamine content (P < 0.05 and P < 0.001 respectively) by 24 h. Placebo had no effect. As for circulating basophils, after 24 h they were decreased by 125 mg MPR (P < 0.05) but increased by 20 mg (P < 0.05). Anti-IgE-induced HR was significantly inhibited by 125 mg MPR (P < 0.05) but not by 20 mg MPR or by the placebo. In contrast, neither MPR (20 mg and 125 mg) nor placebo significantly reduced FMP-induced HR. The strong potentiation by IL-3 of HR evoked by anti-IgE and FMP at baseline (P < 0.001) persisted 24 h after injection of MPR or placebo (P < 0.001 except P < 0.05 for anti-IgE-induced HR after 125 mg MPR).(ABSTRACT TRUNCATED AT 250 WORDS)
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Louis, Renaud ; Université de Liège - ULiège > Département des sciences cliniques > Pneumologie - Allergologie
Bury, Thierry ; Université de Liège - ULiège > Département des sciences de la motricité > Physiologie humaine et physiologie de l'effort physique
Corhay, Jean-Louis ; Université de Liège - ULiège > Département des sciences cliniques > Département des sciences cliniques
Radermecker, Maurice ; Université de Liège - ULiège > Services généraux (Faculté de médecine) > Relations académiques et scientifiques (Médecine)
Language :
English
Title :
Effects of Acute Injection of Methylprednisolone in Man on Immunological and Non-Immunological Histamine Release from Leucocytes and Its Potentiation by Interleukin-3
2 Schleimer R. Effects of glucocorticoids on inflammatory cells relevant to their therapeutic applications in asthma. Am Rev Respir Dis 1990 ; 141: 559–69.
3 Corrigan C. Mechanism of glucocorticoid action in asthma; too little, too late. Clin Exp Allergy 1992 ; 22: 315–17.
4 Marone G. The role of mast cell and basophil activation in human allergic reactions. Eur Respir J 1989 ; 6: 446–55.
5 Nacleirio R, Proud D, Togias A et al. Inflammatory mediators in the late antigen‐induced rhinitis. N Engl J Med 1985 ; 313: 65–70.
6 Liu M, Hubbard W, Proud D. Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Am Rev Respir Dis 1991 ; 144: 51–8.
7 Schleimer R, Lichtenstein L, Gillepsie E. Inhibition of basophil histamine release by anti‐inflammatory steroids. Nature 1991 ; 292: 454–5.
8 Bergstrand H, Björnsson A, Lundqvist B, Nilsson A, Braltsand R. Inhibitory effect of glucocorticosteroids on anti‐IgE‐induced histamine release from human leukocytes: evidence for a dual mechanism of action. Allergy 1984: 39: 217–30.
9 Dunsky E, Zweiman B, Fischlcr E, Levy D. Eariy effects of corticosteroids on basophils. leukocyte histamine and tissue hislaminc. J Allergy Clin Immunol 1979 ; 63: 426–32.
10 Findlay S, Lichtenstein L. Basophil releasabitity in patients with asthma. Am Rev Respir Dis 1980 ; 122: 53–9.
11 Lampl K, Lichtenstein L, Schleimer R. In vitro resistance to dexamethasone of basophils from patients receiving long‐term steroid therapy. Am Rev Respir Dis 1985 ; 132: 1015–8.
12 Hirai K, Morita Y. Misaki Y ei al. Modulation of human basophil histamine release by hemopoietic growth factors. J Immunol 1988 ; 141: 3958–64.
13 Schleimer R, Derse C. Friedman B et al. Regulation nf human basophil mediator release by cytokmes I. Inicraction with anti‐inflammatory steroids. J Imniunol 1989 ; 143: 1310–7.
14 Valent P, Besemer J. Muhm M et al. Interlcukin 3 activates blood basophils via high‐affinity binding sites. Proc Nath Acad Sc USA 1989 ; 86: 5542–6.
15 Nelson D, Morris M. Basic examination of blood. In: Sanders Ed. Clinical diagnosis management by laboratory method, 18th edn, 1991: 553–603.
16 Louis RE, Radermecker MF. Substance P‐induced histamine release from human basophils, skin and lung fragments: Effects of nedocromil sodium and theophylline. Int Arch Appl Immunol 1990 ; 92: 329–33.
17 Bury Th, Radermecker MF. Role of hislaminc in. the chemotactic deactivation of polymorphonuclear leukocytes following incubation with formylmcthionyl peptides. Int Arch Appl Immunol 1992 ; 97: 109–14.
18 Radermecker MF, Louis R, Corhay JL, Bury Th. Cylokine modulation of antigen‐induced basophil histamine release in wasp venom allergy. J Allergy Clin Immunol 1993 ; 91 (abst 626): 297.
19 Saavedra Delgado AM, Mathews K, Pan P et al. Dose‐response studies of the suppression of whole blood histamine and basophil counts by prednisone. J Allergy Clin Immunol 1980 ; 66: 464–71.
20 Schleimer R, McGlashan D, Gillespie E, Lichtenstein L. Inhibition of basophil histamine release by anti‐inflammatory steroids. II Studies on the mechanism of action J Immunol 1982 ; 129: 1632–6.
21 Warner JA, McGlashan DW. Signal transduction events in human basophils. A comparative study of the role of protein kinase C in basophils, in basophils activated by anti‐IgH antibody and formyl‐methionyl‐phenylalanine. J Immimol 1990 ; 145: 1897–1905.
22 Bergstrand H. Lundqvist B. Human basophil histamine release is differently affected by inhibitors of calmodulin, diacylglycerolkinase and peptidyl propyl cis‐trans isomerase in a secretagogue specific manner. Allergy 1992 ; 47: 353–61.
23 Lichtenstein LM, Margolis S. Histamine release in vitro: inhibition by catecholamines and methylxanthines. Science 1968 ; 161: 902.
24 Radermecker M. Gustin M. An in vivo demonstration of the antianaphylactic effect of terbutaline. Clin Allergy 1981 ; 11: 79–86.